• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用表观遗传抗癌剂RRx-001靶向肿瘤缺氧:一种一氧化氮生成的超级激动剂。

Targeting tumor hypoxia with the epigenetic anticancer agent, RRx-001: a superagonist of nitric oxide generation.

作者信息

Fens Marcel H, Cabrales Pedro, Scicinski Jan, Larkin Sandra K, Suh Jung H, Kuypers Frans A, Oronsky Neil, Lybeck Michelle, Oronsky Arnold, Oronsky Bryan

机构信息

Children's Hospital Oakland Research Institute (CHORI), 5700 M.L.K. Jr Way, Oakland, CA, 94609, USA.

Department of Bioengineering, University of California San Diego (UCSD), 9500 Gilman Dr, La Jolla, CA, 92093, USA.

出版信息

Med Oncol. 2016 Aug;33(8):85. doi: 10.1007/s12032-016-0798-9. Epub 2016 Jul 4.

DOI:10.1007/s12032-016-0798-9
PMID:27377482
Abstract

This study reveals a novel interaction between deoxyhemoglobin, nitrite and the non-toxic compound, RRx-001, to generate supraphysiologic levels of nitric oxide (NO) in blood. We characterize the nitrite reductase activity of deoxyhemoglobin, which in the presence of bound RRx-001 reduces nitrite at a much faster rate, leading to markedly increased NO generation. These data expand on the paradigm that hemoglobin generates NO via nitrite reduction during hypoxia and ischemia when nitric oxide synthase (NOS) function is limited. Here, we demonstrate that RRx-001 greatly enhances NO generation from nitrite reduction. RRx-001 is thus the first example of a functional superagonist for nitrite reductase. We hypothesize that physiologically this reaction releases the potentially cytotoxic effector NO selectively in hypoxic tumor regions. It may be that a binary NO-H2O2 trigger is indirectly responsible for the observed tumoricidal activity of RRx-001 since NO is known to inhibit mitochondrial respiration.

摘要

本研究揭示了脱氧血红蛋白、亚硝酸盐与无毒化合物RRx-001之间的一种新型相互作用,可在血液中产生超生理水平的一氧化氮(NO)。我们对脱氧血红蛋白的亚硝酸盐还原酶活性进行了表征,在结合RRx-001的情况下,脱氧血红蛋白能以更快的速率还原亚硝酸盐,从而导致NO生成显著增加。这些数据拓展了血红蛋白在缺氧和缺血期间(此时一氧化氮合酶(NOS)功能受限)通过亚硝酸盐还原生成NO的范例。在此,我们证明RRx-001极大地增强了亚硝酸盐还原产生的NO。因此,RRx-001是亚硝酸盐还原酶功能性超级激动剂的首个实例。我们推测,在生理状态下,该反应在缺氧肿瘤区域选择性释放具有潜在细胞毒性的效应分子NO。由于已知NO可抑制线粒体呼吸,可能是二元NO-H2O2触发机制间接导致了观察到的RRx-001的杀肿瘤活性。

相似文献

1
Targeting tumor hypoxia with the epigenetic anticancer agent, RRx-001: a superagonist of nitric oxide generation.用表观遗传抗癌剂RRx-001靶向肿瘤缺氧:一种一氧化氮生成的超级激动剂。
Med Oncol. 2016 Aug;33(8):85. doi: 10.1007/s12032-016-0798-9. Epub 2016 Jul 4.
2
Nitrite may serve as a combination partner and a biomarker for the anti-cancer activity of RRx-001.亚硝酸盐可能作为RRx-001抗癌活性的联合伙伴和生物标志物。
Biorheology. 2019;56(4):221-235. doi: 10.3233/BIR-190213.
3
Platelet inhibitory effects of the Phase 3 anticancer and normal tissue cytoprotective agent, RRx-001.RRx-001 是一种处于 III 期的抗癌和正常组织细胞保护剂,具有血小板抑制作用。
J Cell Mol Med. 2018 Oct;22(10):5076-5082. doi: 10.1111/jcmm.13791. Epub 2018 Jul 16.
4
A novel hypoxia-selective epigenetic agent RRx-001 triggers apoptosis and overcomes drug resistance in multiple myeloma cells.一种新型的缺氧选择性表观遗传药物RRx-001可引发多发性骨髓瘤细胞凋亡并克服其耐药性。
Leukemia. 2016 Nov;30(11):2187-2197. doi: 10.1038/leu.2016.96. Epub 2016 Apr 27.
5
NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001.对癌症说“不”:一氧化氮及表观遗传一氧化氮供体RRx-001的复杂多面作用
Redox Biol. 2015 Dec;6:1-8. doi: 10.1016/j.redox.2015.07.002. Epub 2015 Jul 2.
6
Epigenetic effects of RRx-001: a possible unifying mechanism of anticancer activity.RRx-001的表观遗传效应:一种可能的抗癌活性统一机制。
Oncotarget. 2015 Dec 22;6(41):43172-81. doi: 10.18632/oncotarget.6526.
7
A look inside the mechanistic black box: Are red blood cells the critical effectors of RRx-001 cytotoxicity?深入探究作用机制的黑匣子:红细胞是RRx-001细胞毒性的关键效应器吗?
Med Oncol. 2016 Jul;33(7):63. doi: 10.1007/s12032-016-0775-3. Epub 2016 May 26.
8
Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration.脱氧肌红蛋白是一种亚硝酸盐还原酶,可生成一氧化氮并调节线粒体呼吸。
Circ Res. 2007 Mar 16;100(5):654-61. doi: 10.1161/01.RES.0000260171.52224.6b. Epub 2007 Feb 9.
9
RRx-001, an epigenetic-based radio- and chemosensitizer, has vascular normalizing effects on SCCVII and U87 tumors.RRx-001是一种基于表观遗传学的放射和化学增敏剂,对SCCVII和U87肿瘤具有血管正常化作用。
Clin Epigenetics. 2016 May 11;8:53. doi: 10.1186/s13148-016-0220-7. eCollection 2016.
10
The immunomodulatory anticancer agent, RRx-001, induces an interferon response through epigenetic induction of viral mimicry.免疫调节抗癌药物RRx-001通过病毒模拟的表观遗传诱导来引发干扰素反应。
Clin Epigenetics. 2017 Jan 19;9:4. doi: 10.1186/s13148-017-0312-z. eCollection 2017.

引用本文的文献

1
Anti-tumor and anti-metastatic effects of RRx-001 on hepatocellular carcinoma: mechanisms of action and therapeutic potential.RRx-001对肝细胞癌的抗肿瘤和抗转移作用:作用机制及治疗潜力
Front Pharmacol. 2024 Nov 27;15:1469825. doi: 10.3389/fphar.2024.1469825. eCollection 2024.
2
RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist.RRx-001:一种嵌合型三重作用的NLRP3抑制剂、Nrf2诱导剂和一氧化氮超激动剂。
Front Oncol. 2023 May 29;13:1204143. doi: 10.3389/fonc.2023.1204143. eCollection 2023.
3
Clinical Course of Two Patients with COVID-19 Respiratory Failure After Administration of the Anticancer Small Molecule, RRx-001.

本文引用的文献

1
Epigenetic effects of RRx-001: a possible unifying mechanism of anticancer activity.RRx-001的表观遗传效应:一种可能的抗癌活性统一机制。
Oncotarget. 2015 Dec 22;6(41):43172-81. doi: 10.18632/oncotarget.6526.
2
Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study.RRx-001 治疗晚期癌症患者的安全性和活性:首次人体、开放标签、剂量递增的 1 期研究。
Lancet Oncol. 2015 Sep;16(9):1133-1142. doi: 10.1016/S1470-2045(15)00089-3. Epub 2015 Aug 19.
3
NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001.
两名新冠肺炎呼吸衰竭患者在给予抗癌小分子药物RRx-001后的临床病程
Int Med Case Rep J. 2022 Dec 15;15:735-738. doi: 10.2147/IMCRJ.S389690. eCollection 2022.
4
RRx-001, a first-in-class small molecule inhibitor of MYC and a downregulator of CD47, is an "erythrophagoimmunotherapeutic".RRx-001是一种一流的MYC小分子抑制剂和CD47下调剂,是一种“红细胞吞噬免疫疗法”。
Oncoimmunology. 2020 Apr 3;9(1):1746172. doi: 10.1080/2162402X.2020.1746172.
5
Desperate Times, Desperate Measures: The Case for RRx-001 in the Treatment of COVID-19. desperation times, desperate measures: the case for rrx-001 in the treatment of covid-19.
Semin Oncol. 2020 Oct;47(5):305-308. doi: 10.1053/j.seminoncol.2020.07.002. Epub 2020 Jul 7.
6
Platelet inhibitory effects of the Phase 3 anticancer and normal tissue cytoprotective agent, RRx-001.RRx-001 是一种处于 III 期的抗癌和正常组织细胞保护剂,具有血小板抑制作用。
J Cell Mol Med. 2018 Oct;22(10):5076-5082. doi: 10.1111/jcmm.13791. Epub 2018 Jul 16.
对癌症说“不”:一氧化氮及表观遗传一氧化氮供体RRx-001的复杂多面作用
Redox Biol. 2015 Dec;6:1-8. doi: 10.1016/j.redox.2015.07.002. Epub 2015 Jul 2.
4
The capacity of red blood cells to reduce nitrite determines nitric oxide generation under hypoxic conditions.红细胞还原亚硝酸盐的能力决定了缺氧条件下一氧化氮的生成。
PLoS One. 2014 Jul 9;9(7):e101626. doi: 10.1371/journal.pone.0101626. eCollection 2014.
5
Development of methods for the bioanalysis of RRx-001 and metabolites.RRx-001及其代谢物生物分析方法的开发。
Bioanalysis. 2014 Apr;6(7):947-56. doi: 10.4155/bio.13.331.
6
The implications of hyponitroxia in cancer.低亚硝酸盐血症在癌症中的影响。
Transl Oncol. 2014 Apr;7(2):167-73. doi: 10.1016/j.tranon.2014.02.001. Epub 2014 Mar 4.
7
Two Case Reports of Resensitization to Previous Chemotherapy with the Novel Hypoxia-Activated Hypomethylating Anticancer Agent RRx-001 in Metastatic Colorectal Cancer Patients.转移性结直肠癌患者对新型缺氧激活型去甲基化抗癌药物RRx-001既往化疗重新致敏的两例病例报告
Case Rep Oncol. 2014 Jan 24;7(1):79-85. doi: 10.1159/000358382. eCollection 2014 Jan.
8
Oxidative stress causes epigenetic alteration of CDX1 expression in colorectal cancer cells.氧化应激导致结直肠癌细胞中 CDX1 表达的表观遗传改变。
Gene. 2013 Jul 25;524(2):214-9. doi: 10.1016/j.gene.2013.04.024. Epub 2013 Apr 22.
9
The yin and yang of nitric oxide in cancer progression.一氧化氮在癌症进展中的阴阳两面。
Carcinogenesis. 2013 Mar;34(3):503-12. doi: 10.1093/carcin/bgt034. Epub 2013 Jan 25.
10
How cancer metabolism is tuned for proliferation and vulnerable to disruption.癌症代谢是如何为增殖而调整的,以及它是如何容易受到干扰的。
Nature. 2012 Nov 15;491(7424):364-73. doi: 10.1038/nature11706.